167 related articles for article (PubMed ID: 33320292)
1. [Anti-VEGF-therapy of fibrovascular and serous-vascularized pigment epithelial detachment in neovascular AMD : A retrospective five-year-analysis].
Barth T; Reiners M; Zeman F; Greslechner R; Helbig H; Gamulescu MA
Ophthalmologe; 2021 Dec; 118(12):1255-1263. PubMed ID: 33320292
[TBL] [Abstract][Full Text] [Related]
2. Response of vascular pigment epithelium detachment due to age-related macular degeneration to monthly treatment with ranibizumab: the prospective, multicentre RECOVER study.
Clemens CR; Wolf A; Alten F; Milojcic C; Heiduschka P; Eter N
Acta Ophthalmol; 2017 Nov; 95(7):683-689. PubMed ID: 28084038
[TBL] [Abstract][Full Text] [Related]
3. Prediction of retinal pigment epithelial tear in serous vascularized pigment epithelium detachment.
Clemens CR; Bastian N; Alten F; Milojcic C; Heiduschka P; Eter N
Acta Ophthalmol; 2014 Feb; 92(1):e50-6. PubMed ID: 23819839
[TBL] [Abstract][Full Text] [Related]
4. OPTIMAL MANAGEMENT OF PIGMENT EPITHELIAL DETACHMENTS IN EYES WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
Khanani AM; Eichenbaum D; Schlottmann PG; Tuomi L; Sarraf D
Retina; 2018 Nov; 38(11):2103-2117. PubMed ID: 29697591
[TBL] [Abstract][Full Text] [Related]
5. WRINKLED VASCULARIZED RETINAL PIGMENT EPITHELIUM DETACHMENT PROGNOSIS AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY.
Lam D; Semoun O; Blanco-Garavito R; Jung C; Nguyen DT; Souied EH; Mimoun G
Retina; 2018 Jun; 38(6):1100-1109. PubMed ID: 28520639
[TBL] [Abstract][Full Text] [Related]
6. Response of Pigment Epithelial Detachment to Anti-Vascular Endothelial Growth Factor Treatment in Age-Related Macular Degeneration.
Cho HJ; Kim KM; Kim HS; Lee DW; Kim CG; Kim JW
Am J Ophthalmol; 2016 Jun; 166():112-119. PubMed ID: 27048998
[TBL] [Abstract][Full Text] [Related]
7. Volumetric Analysis of Vascularized Serous Pigment Epithelial Detachment Progression in Neovascular Age-Related Macular Degeneration Using Optical Coherence Tomography Angiography.
Au A; Hou K; Dávila JP; Gunnemann F; Fragiotta S; Arya M; Sacconi R; Pauleikhoff D; Querques G; Waheed N; Freund KB; Sadda S; Sarraf D
Invest Ophthalmol Vis Sci; 2019 Aug; 60(10):3310-3319. PubMed ID: 31369033
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal anti-VEGF therapy for vascularized pigment epithelium detachment in age-related macular degeneration.
Giansanti F; Bacherini D; Giacomelli G; Virgili G; Finocchio L; Fiore T; Vannozzi L; Menchini U
Eur J Ophthalmol; 2014; 24(3):402-8. PubMed ID: 24242217
[TBL] [Abstract][Full Text] [Related]
9. Prospective PED-study of intravitreal aflibercept for refractory vascularized pigment epithelium detachment due to age-related macular degeneration: morphologic characteristics of non-responders in optical coherence tomography.
Clemens CR; Alten F; Termühlen J; Mihailovic N; Rosenberger F; Heiduschka P; Eter N
Graefes Arch Clin Exp Ophthalmol; 2020 Jul; 258(7):1411-1417. PubMed ID: 32306096
[TBL] [Abstract][Full Text] [Related]
10. Comparison of anti-VEGF therapies on fibrovascular pigment epithelial detachments in age-related macular degeneration.
Au A; Parikh VS; Singh RP; Ehlers JP; Yuan A; Rachitskaya AV; Sears JE; Srivastava SK; Kaiser PK; Schachat AP; Martin DF; Modi Y
Br J Ophthalmol; 2017 Jul; 101(7):970-975. PubMed ID: 27913442
[TBL] [Abstract][Full Text] [Related]
11. Alternating Bi-Weekly Intravitreal Ranibizumab and Bevacizumab for Refractory Neovascular Age-Related Macular Degeneration with Pigment Epithelial Detachment
Witkin AJ; Rayess N; Garg SJ; Maguire JI; Storey P; Kaiser RS; Hsu J; Vander JF; Ho AC
Semin Ophthalmol; 2017; 32(3):309-315. PubMed ID: 26337539
[TBL] [Abstract][Full Text] [Related]
12. RETINAL PIGMENT EPITHELIAL TEAR AFTER INTRAVITREAL RANIBIZUMAB TREATMENT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
Cho HJ; Kim HS; Yoo SG; Han JI; Lew YJ; Cho SW; Lee TG; Kim JW
Retina; 2016 Oct; 36(10):1851-9. PubMed ID: 27074658
[TBL] [Abstract][Full Text] [Related]
13. Multilayered pigment epithelial detachment in neovascular age-related macular degeneration.
Rahimy E; Freund KB; Larsen M; Spaide RF; Costa RA; Hoang Q; Christakopoulos C; Munch IC; Sarraf D
Retina; 2014 Jul; 34(7):1289-95. PubMed ID: 24675391
[TBL] [Abstract][Full Text] [Related]
14. Alterations of vascular pigment epithelium detachments associated with age-related macular degeneration during upload with intravitreal ranibizumab.
Wolf A; Rüping J; Neubauer AS; Mayer W; Ulbig M; Haritoglou C; Holz FG; Eter N; Kampik A
Retina; 2013 Oct; 33(9):1843-9. PubMed ID: 23598795
[TBL] [Abstract][Full Text] [Related]
15. Clinical response of pigment epithelial detachment associated with neovascular age-related macular degeneration in switching treatment from Ranibizumab to Aflibercept.
Tyagi P; Juma Z; Hor YK; Scott NW; Ionean A; Santiago C
BMC Ophthalmol; 2018 Jun; 18(1):148. PubMed ID: 29929478
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal ranibizumab for the treatment of fibrovascular pigment epithelial detachment in age-related macular degeneration.
Iordanous Y; Powell AM; Mao A; Hooper PL; Eng KT; Schwartz C; Kertes PJ; Sheidow TG
Can J Ophthalmol; 2014 Aug; 49(4):367-76. PubMed ID: 25103655
[TBL] [Abstract][Full Text] [Related]
17. Prognosti implications of pigment epithelial detachment in bevacizumab (avastin)-treated eyes with age-related macular degeneration and choroidal neovascularization.
Freeman WR; Kozak I; Yuson RM; Nigam N; Cheng L; Mojana F
Retina; 2011 Oct; 31(9):1812-8. PubMed ID: 21866073
[TBL] [Abstract][Full Text] [Related]
18. Morphological characteristics of eyes with neovascular age-related macular degeneration and good long-term visual outcomes after anti-VEGF therapy.
Fang M; Chanwimol K; Maram J; Datoo O'Keefe GA; Wykoff CC; Sarraf D; Brown A; Lampen SIR; Zhou B; Rusakevich AM; Sadda S
Br J Ophthalmol; 2023 Mar; 107(3):399-405. PubMed ID: 34561217
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of Intravitreal Injection of Ranibizumab for Neovascular Age-Related Macular Degeneration with Serous Pigment Epithelial Detachment.
Zhao C; Zhang Z; Chen L; Wang F; Xu D
Med Sci Monit; 2016 Mar; 22():833-9. PubMed ID: 26972376
[TBL] [Abstract][Full Text] [Related]
20. Second eyes to develop neovascular age-related macular degeneration have fewer symptoms and better one-year visual outcomes.
Akkan Aydoğmuş FS; Onwuka O; Saddemi J; Lasalle CC; Ramsey DJ
BMC Ophthalmol; 2023 Jul; 23(1):303. PubMed ID: 37420309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
